Lv51
1470 积分 2022-05-17 加入
The breast cancer drug market 2024
18天前
已完结
The breast cancer drug market
18天前
已完结
Haemopoiesis – the formation of blood cells
18天前
已完结
The present and future of bispecific antibodies for cancer therapy
19天前
已完结
Cancer therapy with antibodies
19天前
已完结
Dose selection of novel anticancer drugs: exposing the gap between selected and required doses
20天前
已完结
Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer
21天前
已完结
Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
21天前
已完结
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study
23天前
已完结
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis
26天前
已完结
皖公网安备34019202002308
